IP Verse

Ter Meer Und Partner patent opposition analysis

The comprehensive analysis of Ter Meer Und Partner opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Ter Meer Und Partner

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP4031110	Dosage Forms For Tyk2 Inhibitors	BRISTOL-MYERS SQUIBB COMPANY	Sep 23, 2026	SANDOZ
EP4000608	Pharmaceutical Composition, Methods For Treating And Uses Thereof	BOEHRINGER INGELHEIM INTERNATIONAL GMBH	Sep 3, 2026	GENERICS UK
EP4349406	Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole For Use As A Medicament	PFIZER INC.	Sep 3, 2026	HOLLATZ
EP4364724	High Concentration Vegf Receptor Fusion Protein Containing Formulations	REGENERON PHARMACEUTICALS, INC.	Aug 24, 2026	INTAS PHARMACEUTICALS
EP3943466	A Filler Compound And Use Of A Filler Compound	SAINT-GOBAIN PLACO	Aug 4, 2026	AECHTER
EP4374919	Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS, INC.	Jul 29, 2026	LUIGI
EP2396005	Sglt-2 Inhibitor For Treating Type 1 Diabetes Mellitus, Type 2 Diabete Mellitus, Impaired Glucose Tolerance Or Hyperglycemia	BOEHRINGER INGELHEIM INTERNATIONAL GMBH	Jul 24, 2026	GENERICS UK
EP3752180	Methods For Treating Cancer With Anti-Pd-1 Antibodies	MERCK SHARP & DOHME LLC	Jul 22, 2026	ABBOTT PRODUCTION OPERATIONS
EP3858859	Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)	BRISTOL-MYERS SQUIBB COMPANY	Jul 13, 2026	MANZER
EP3756650	Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-Dione	AMGEN (EUROPE) GMBH	May 20, 2026	SANDOZ

Top companies who are the clients of Ter Meer Und Partner

Company	Total
GENERICS UK	28
AECHTER	13
SANDOZ	8
HEXAL	8
TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBB	8
ACCORD HEALTHCARE	4
HOLLATZ	3
ACTAVIS GROUP PTC EHF	3
LUIGI	3
PAUL HARTMANN	3